# Vinorelbine

## Navelbine 20mg

##### 臨採

| 藥品代碼   | ONAV2                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Non-small cell lung cancer. Metastatic breast cancer.                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 用法用量   | As a single agent， first three administrations: 60 mg/m2 once weekly. Beyond the third administration， it is recommended to increase the dose to 80mg/m2 once weekly except in those patients for whom the neutrophil count dropped once < 500/mm3 or 500-1000/mm3 during the first three administrations at 60mg/m2                                                                                                                                                    |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌       | Disease significantly affecting absorption; previous significant surgical resection of stomach or small bowel. Severe hepatic impairment; pregnancy & lactation; patients requiring long-term O2 therapy. Coadministration with meningocococal conjugate vaccine or other live virus vaccines， phenytoin & itraconazole. Pretreatment granulocyte counts <1000/mm3                                                                                                       |
| 副作用     | Neutropenia， anemia， thrombocytopenia; nausea & vomiting， diarrhea， anorexia， stomatitis， esophagitis; loss of tendon reflexes， neuromotor disorders， neuroconstipation (rarely progressing to paralytic ileus); alopecia; fatigue， fever， arthralgia including jaw pain， myalgia， pain including pain at tumor site. Vial Ischemic cardiac disease (rare)， abnormal liver function tests， dyspnea， bronchospasm， generalized cutaneous reactions (rare). |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                                                                                                        |

## NAVELBINE 30mg

##### 

| 藥品代碼   | ONAV3                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Non-small cell lung cancer. Metastatic breast cancer.                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 用法用量   | As a single agent， first three administrations: 60 mg/m2 once weekly. Beyond the third administration， it is recommended to increase the dose to 80mg/m2 once weekly except in those patients for whom the neutrophil count dropped once < 500/mm3 or 500-1000/mm3 during the first three administrations at 60mg/m2.                                                                                                                                                   |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌       | Disease significantly affecting absorption; previous significant surgical resection of stomach or small bowel. Severe hepatic impairment; pregnancy & lactation; patients requiring long-term O2 therapy. Coadministration with meningocococal conjugate vaccine or other live virus vaccines， phenytoin & itraconazole. Pretreatment granulocyte counts <1000/mm3                                                                                                       |
| 副作用     | Neutropenia， anemia， thrombocytopenia; nausea & vomiting， diarrhea， anorexia， stomatitis， esophagitis; loss of tendon reflexes， neuromotor disorders， neuroconstipation (rarely progressing to paralytic ileus); alopecia; fatigue， fever， arthralgia including jaw pain， myalgia， pain including pain at tumor site. Vial Ischemic cardiac disease (rare)， abnormal liver function tests， dyspnea， bronchospasm， generalized cutaneous reactions (rare). |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                            |

